Biosimilar Collaborations Ireland Limited
SpainAll drugs from this manufacturer
-
It is used to treat several types of cancer in adults, including advanced colon or rectal cancer, metastatic breast cancer, advanced non-small cell lung cancer, advanced renal cancer, primary epithelial ovarian, fallopian tube, or peritoneal cancer, and persistent, recurrent, or metastatic cervical cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage bevacizumab 25 mg/ml -
It is used to treat postmenopausal osteoporosis in women and osteoporosis in men at risk of fracture. It is also used to treat bone loss caused by testosterone reduction in patients with prostate cancer or bone loss due to prolonged glucocorticoid use in individuals at high risk of fracture.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage denosumab 60 mg -
It is used to reduce the duration of neutropenia (low white blood cell count) and the frequency of febrile neutropenia (low white blood cell count with fever) that may occur after receiving chemotherapy.
Dosage form: solution for injection
Active substance Dosage pegfilgrastim 6 mg -
It is used to treat various inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, psoriasis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, ankylosing spondylitis, non-infectious uveitis, and polyarticular juvenile idiopathic arthritis.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage adalimumab 40 mg -
It is used in adults to treat rheumatoid arthritis, psoriatic arthritis, severe axial spondyloarthritis (including ankylosing spondylitis), and mild to moderate psoriasis. It is also prescribed in children and adolescents for certain types of juvenile idiopathic arthritis and severe psoriasis, provided they meet the indicated weight and age requirements.
Dosage form: solution for injection in pre-filled pen
Active substance Dosage etanercept 50 mg/ml -
It is prescribed for the treatment of early or metastatic breast cancer, and metastatic gastric cancer, provided that the tumor cells have high levels of a protein called HER2.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 150 mg -
It is prescribed for the treatment of early or metastatic breast cancer, and metastatic gastric cancer, provided they show high levels of the HER2 protein.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage trastuzumab 420 mg -
It is used for the treatment of diabetes mellitus in adults, adolescents, and children aged 2 years and older. It helps lower blood sugar through prolonged and consistent action.
Dosage form: solution for injection
Active substance Dosage insulin glargine 100 U U -
It is used to treat moderate to severe Crohn's disease in adults, specifically when other medications have not worked adequately or cannot be tolerated.
Dosage form: solution for infusion, concentrate
Active substance Dosage ustekinumab 5 mg/ml -
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and Crohn's disease (in adults).
Dosage form: solution for injection
Active substance Dosage ustekinumab 45 mg -
It is used to treat inflammatory diseases such as plaque psoriasis (in adults and children aged 6 years and older), psoriatic arthritis (in adults), and moderate to severe Crohn's disease (in adults).
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage ustekinumab 90 mg